21647 ⎘
Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups -
NERIDRONIC ACID FOR TREATING COMPLEX REGIONAL PAIN SYNDROME
#1202Treatment of Rb-negative tumors using topoisomerase with cyclin dependent kinase 4/6 inhibitors
#1203Multi-drug therapies for tuberculosis treatment
#1204Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
#1205Use of histone deacetylase inhibitors for enhancing immunotherapies
#1206CONTROLLED DOSING OF CLOPIDOGREL WITH GASTRIC ACID INHIBITION THERAPIES
#1207THERAPEUTIC AGENT FOR DYSLIPIDEMIA
#1208Glucocorticoid receptor modulators to treat pancreatic cancer
#1209Compositions comprising melatonin
#1210Compositions and methods for preventing and recovery from detrimental effects of alcohol consumption
#1211Biophotonic compositions for the treatment of otitis externa
#1212QUALITY OF LIFE EXTENSION THERAPIES RELATING TO AGING, FOOD ALLERGIES, PAIN AND REDUCED VIGOR BY MANAGING MOLECULAR, CELLULAR AND SUBCELLULAR BIOCHEMICAL REQUIREMENTS OF MITOCHONDRIA AND OTHER ORGANELLE PROCESSES
#1213DPA-ENRICHED COMPOSITIONS OF OMEGA-3 POLYUNSATURATED FATTY ACIDS IN FREE ACID FORM
#1214Method, composition and package for bowel cleansing
#1215Combination composition
#1216COMPOSITION FOR REDUCING FREQUENCY OF URINATION, METHOD OF MAKING AND USE THEREOF
#1217Sumatriptan promethazine pharmaceutical compositions
#1218High surface-area lyophilized compositions comprising arsenic for oral administration in patients
#1219Topical testosterone (T) for promoting hair growth—containing formulations
#1220TOBACCO COMPOSITIONS
#1221Treatment of filaggrin (FLG) related diseases by modulation of FLG expression and activity
#1222Therapeutic apoptotic cell preparations, method for producing same and uses thereof
#1223Immunologic treatment of cancer
#1224METHODS AND COMPOSITIONS FOR MODULATING DRUG-POLYMER ARCHITECTURE, PHARMACOKINETICS AND BIODISTRIBUTION
#1225FUMAGILLOL SPIROCYCLIC COMPOUNDS AND FUSED BICYCLIC COMPOUNDS AND METHODS OF MAKING AND USING SAME
#1226Broad spectrum antibacterial activity of novel bisbenzimidazoles targeting topoisomerase IA and the synergistic composition of bisbenzimidazole with efflux pump inhibitors against pathogenic bacteria
#1227Nanoparticle-cell construct with platinum anti-cancer agent
#1228Osteotropic nanoparticles for prevention or treatment of bone metastases
#1229Stabilized vancomycin formulations
#1230Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity
#1231Cancer vaccines and methods of delivery
#1232Individualized Immunomodulation Therapy for Neurodegenerative Disorders, CNS Injury and Age-Related Dementia
#1233MODULATION OF YEAST-BASED IMMUNOTHERAPY PRODUCTS AND RESPONSES
#1234Mutant glyceraldehyde-3-phosphate dehydrogenase (GAPDH) compositions and methods of treating cancer
#1235IL-15-based molecules and methods of use thereof
#1236Mutant peptides and methods of treating subjects using the same
#1237Isolated polypeptide and compositions comprising same
#1238USE OF MK2 INHIBITOR PEPTIDE-CONTAINING COMPOSITIONS FOR TREATING NON-SMALL CELL LUNG CANCER WITH SAME
#1239Treatment of Constipation-Predominant Irritable Bowel Syndrome
#1240COMPOSITIONS AND METHODS FOR PREVENTING OR TREATING DISEASES, CONDITIONS, OR PROCESSES CHARACTERIZED BY ABERRANT FIBROBLAST PROLIFERATION AND EXTRACELLULAR MATRIX DEPOSITION
#1241METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY
#1242ORAL ANTI-INFLAMMATORY PEPTIDES TO TREAT EPILEPSY, SEIZURES AND CNS DISORDERS
#1243METHODS AND COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF PULMONARY ARTERIAL HYPERTENSION
#1244Fast acting inhibitor of gastric acid secretion
#1245TREATMENT FOR CHITIN-CONTAINING MICROORGANISMS
#1246RNAi therapy for hepatitis B virus infection
#1247Carboline derivatives or phosphorous derivatives for the treatment of muscular myopathies and traumatic injuries to muscles
#1248AQUEOUS BASED CAPSAICINOID FORMULATIONS AND METHODS OF MANUFACTURE AND USE
#1249Multiphasic contraceptive regimen for oral combination drug formulation of progestin and estrogen
#1250Compositions and methods for inhibiting Dkk-1
#1251Small molecule inhibitors of the nuclear translocation of androgen receptor for the treatment of castration-resistant prostate cancer
#1252Use of low dose emetine for inhibition of human cytomegalovirus (HCMV)
#1253Crystalline forms of a prolyl hydroxylase inhibitor
#1254Compositions and methods for prophylaxis and treatment of addictions
#1255METHODS OF TREATING PULMONARY DISEASES AND DISORDERS
#1256Compositions and methods for treating plasma cell disorders and B-cell prolymphocytic disorders
#1257Methods and pharmaceutical compositions for reducing arterial stiffness with a combination of a therapeutic agent blocking the angiotensin receptor and a therapeutic agent inhibiting the NEP enzyme
#1258Uses of indolinone compounds
#1259Polyphenol-reactive oxygen species compositions and methods
#1260METHODS OF USING CASPASE INHIBITORS IN TREATMENT OF LIVER DISEASE
#1261Extended, delayed and immediate release formulation method of manufacturing and use thereof
#1262CAPSAICIN SEQUENTIAL DOSING METHOD FOR TREATMENT OF MORTON'S NEUROMA PAIN
#1263TREATMENT OF HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS
#1264Formulation and process for modulating wound healing
#1265NANOPARTICLE COMPRISING RAPAMYCIN AND ALBUMIN AS ANTICANCER AGENT
#1266COMPOSITIONS FOR SUSTAINED RELEASE OF ANTI-GLAUCOMA AGENTS TO CONTROL INTRAOCULAR PRESSURE
#1267ANTI-INFECTION AUGMENTATION FOAMABLE COMPOSITIONS AND KIT AND USES THEREOF
#1268Saponin and bacterial compositions and methods
#1269Compositions comprising peroxyacid and methods for producing and using the same
#1270Methods for inducing migration by dendritic cells and an immune response
#1271Anti-CD20 combinations for treating tumors
#1272Activatable anti-PDL1 antibodies, and methods of use thereof
#1273Anti-CD43 antibody and use thereof for cancer treatment
#1274Anti-EGFR combinations for treating tumors
#1275Phenylpropanoid compound and preparation method and use thereof
#1276TDO2 Inhibitors
#1277Heterocyclic inhibitors of ATR kinase
#1278TRPA1 modulators
#1279SALTS OF COMPOUNDS HAVING A BENZIMIDAZOLIC STRUCTURE, USES AND PROCESS FOR THE PREPARATION THEREOF
#1280Azepane derivatives and methods of treating hepatitis B infections
#1281ELP fusion proteins for controlled and sustained release
#1282Pre-mixed, ready-to-use pharmaceutical compositions
#1283Methods for manufacturing phthalocyanine dye conjugates and stable conjugates
#1284Combination therapy using REIC/Dkk-3 gene and a checkpoint inhibitor
#1285Method of treating diabetic nephropathy comprising administering plasminogen
#1286Methods and compositions for treating neurodegenerative and neuroinflammatory conditions
#1287Treatment and Prevention of Bone and Joint Disorders
#1288PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
#1289DOSAGE FORMS FOR ORAL ADMINISTRATION OF ZOLEDRONIC ACID OR RELATED COMPOUNDS FOR TREATING DISEASE
#1290Lipid compositions with high DHA content
#1291Lipid disulfide prodrugs and uses related thereto
#1292METHODS AND RELATED COMPOSITIONS FOR REDUCTION OF FAT AND SKIN TIGHTENING
#1293REGULATION OF GENE EXPRESSION BY MODULATING PRIMARY CILIA LENGTH
#1294Deuterated analogs of etifoxine, their derivatives and uses thereof
#1295Therapeutic agent for FGFR inhibitor-resistant cancer
#1296Formulations of 5-fluorocytosine and uses thereof
#1297Kinase inhibitors for treatment of disease
#1298Niacin formulation
#1299Antifungal Compositions
#1300Use of 4-Aminopyridine to Improve Neuro-Cognitive and/or Neuro-Psychiatric Impairment in Patients with Demyelinating and Other Nervous System Conditions
#1301THE USE OF A TEMPORARY INHIBITOR OF P53 FOR PREVENTING OR REDUCING CANCER RELAPSE
#1302Treatment of Gout and Hyperuricemia
#1303Compositions comprising corneoscleral tissue cross-linking agents
#1304Treatment and prevention of joint disorders
#1305Cannabinoid Formulation and Products
#1306CNS-accessible pharmacological chaperones for treatment of acid β-glucosidase-related disease states
#1307Compositions for Use in Treating Pulmonary Arterial Hypertension
#1308Compositions and methods for treating autism
#1309Compositions and methods for treating autism
#1310POLYTHERAPY MODULATING CATHELICIDIN GENE EXPRTESSION MODULATION FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND OTHER CONDITIONS
#1311Valproic acid for the treatment or prevention of pathological conditions associated with excess fibrin deposition and/or thrombus formation
#1312Nutritional compositions comprising hydrolyzed protein and a modified fat system and uses thereof
#1313Bioprotection using lactobacillus paracasei strains
#1314Triple combination antibody therapies
#1315Polypeptide for inhibition of tumor
#1316PYRIDIN-3-YL ACETIC ACID DERIVATIVES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION
#1317Arylalkyl- and aryloxyalkyl-substituted epithelial sodium channel blocking compounds
#13181-ARYL-3-AMINOALKOXY PYRAZOLES AS SIGMA LIGANDS ENHANCING ANALGESIC EFFECT OF OPIOIDS AND ATTENUATING THE DEPENDENCY THEREOF
#1319Progesterone formulations
#1320IL-12 P40 monomer, monoclonal antibody against P40 homodimer and the combination of the two for autoimmune disease treatment
#1321Localized immunosuppression of allografts for peripheral nerve repair
#1322Localized immunosuppression of allografts for peripheral nerve repair
#1323Methods for inhibiting tumor growth
#1324Use of annexin V to reduce the spread of intracellular pathogens
#1325COMPOSITIONS FOR MANAGEMENT OF WOUNDS, SKIN DISEASES, DEHYDRATION, CHRONIC DISEASES, AND RESPIRATORY DISEASES
#1326Tumor infiltrating lymphocytes and methods of therapy
#1327Methods and Systems for the Prevention, Treatment and Management of Disease and Effects of Aging Via Cell-to-Cell Restoration Therapy Using Subcellular Transactions
#1328MiRNA biomarkers for cartilage degeneration
#1329Compositions comprising nicotinamide riboside and a urolithin
#1330TREATMENT FOR CANCER BY A COMBINATION OF AN INOSITOL PHOSPHORIC DERIVATIVE AND MAGNESIUM CHLORIDE
#1331COMPOSITIONS AND METHOD FOR REDUCING CARDIOTOXICITY
#1332COMPOSITIONS AND METHODS FOR LIPID METABOLISM DISORDER
#1333Pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease
#1334Therapeutic Combinations of a MEK Inhibitor and a BTK Inhibitor
#1335Method and Therapeutic/Cosmetic Topical Compositions for the Treatment of Rosacea and Skin Erythema Using A1-Adrenoceptor Agonists
#1336CANCER TREATMENT METHOD
#1337Method for treating a protozoal infection
#1338Antiproliferative compounds and methods of use thereof
#1339Compositions and kits useful for treatment of respiratory illness
#1340Use of flecainide as an anti-connexin agent and method for potentiating the effects of a psychotropic drug
#1341Bis-amines, compositions, and uses related to CXCR4 inhibition
#1342Hyperphenylalaninemia and treatments thereof
#1343COMPOSITIONS FOR THE TREATMENT OF PRESBYOPIA
#1344Methods and Compositions Using Cetyl Myristoleate (CMO) In Medical Treatments
#1345Method for extending lifespan delaying the onset of age-related disease
#1346BUPROPION AND DEXTROMETHORPHAN FOR TREATING NICOTINE ADDICTION
#1347Use of fenoterol and fenoterol analogues in the treatment of glioblastomas and astrocytomas
#1348Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects
#1349Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects
#1350Celecoxib and amlodipine formulation and method of making the same
#1351COPPER INTRAUTERINE DEVICE
#1352Oral Hygiene Products and Method of Using the Same
#1353Container assembly
#1354Antihistamines Combined with Dietary Supplements for Improved Health
#1355Anti-CD33 antibodies and methods of use thereof
#1356Human antibodies against rabies and uses thereof
#1357GLYCOPROTEINS HAVING LIPID MOBILIZING PROPERTIES AND THERAPEUTIC USES THEREOF
#1358Silane-Containing Heterocyclic Compounds and Methods of Use Thereof for the Treatment of Viral Diseases
#1359Immunoregulatory agents
#1360Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus
#1361Process for preparing an anti-cancer agent, 1-((4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-6-methoxyquinolin-7-yloxy)methyl)cyclopropanamine, its crystalline form and its salts
#1362Compositions and methods of use of phorbol esters in the treatment of neoplasms
#1363PROPHYLACTIC NORMALIZATION OF CUTANEOUS WOUND REPAIR
#1364SINGLE-DOSE ADMINISTRATION OF FACTOR VIIa
#1365DIETARY SUPPLEMENTS AND FORMULATIONS
#1366DIETARY SUPPLEMENTS AND FORMULATIONS
#1367Methods of treating lung cancer
#1368Pre-filled pharmaceutical package comprising a liquid formulation of a VEGF-antagonist
#1369Methods for the regulation of matrix metalloproteinase expression
#1370INHIBITING OR INACTIVATING THE VIRULENCE OF A LIVE PATHOGEN
#1371Composition, containing extracts of and as active ingredients, for promoting motor ability and muscles
#1372IMMUNE EFFECTOR CELL THERAPIES WITH ENHANCED EFFICACY
#1373STABILIZED ANTISEPTIC PREPARATIONS
#1374MATERIALS AND METHODS FOR TREATMENT OF CYSTIC FIBROSIS AND FOR INDUCTION OF ION SECRETION
#1375MTH1 inhibitors for treatment of inflammatory and autoimmune conditions
#1376TREATMENT OF GENOTYPED DIABETIC PATIENTS WITH DPP-IV INHIBITORS SUCH AS LINAGLIPTIN
#1377Method of treating a brain tumor
#1378Synthetic lethality and the treatment of cancer
#1379BUPROPION AS A MODULATOR OF DRUG ACTIVITY
#1380ABUSE-RESISTANT MUCOADHESIVE DEVICES FOR DELIVERY OF BUPRENORPHINE
#1381Compositions and methods for treating drug-tolerant glioblastoma
#1382ANTICHOLINERGIC NEUROPROTECTIVE COMPOSITION AND METHODS
#1383Composition comprising combination of rapamycin and an activator of AMP kinase and use thereof for treating diseases
#1384Antifungal compounds
#1385Organic compounds
#1386DRUG COMBINATION PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USING THEM
#1387Composition comprising a diindolylmethane and a retinoid to treat a skin condition
#1388Tumor therapeutic agent
#1389Methods of diagnosing and treating infected implants
#1390COMBINATION MEDICATION FOR NEURO-DEGENERATIVE DISEASES AND SIDE-EFFECTS ASSOCIATED WITH COGNITION EFFECTING PHARMACEUTICALS
#1391USE OF RASAGILINE FOR THE TREATMENT OF RESTLESS LEGS SYNDROME
#1392Emulsion formulations of an NK-1 receptor antagonist and uses thereof
#1393ANTIBODY MOLECULES TO PD-1 AND USES THEREOF
#1394PEPTIDOMIMETIC MACROCYCLES AND USES THEREOF
#1395Compounds and compositions for inhibition of FASN
#1396Combination compositions
#1397Vitamin D3 and analogs thereof for treating alopecia
#1398Anti-LAG3 antibodies and antigen-binding fragments
#1399Compositions and methods of treating sarcoma lung metastasis
#1400Treatment of diabetic nerve injury comprising administering plasminogen
#1401Methods and compositions for oral administration of proteins
#1402Use of FGF19 to increase muscle fiber size
#1403Compositions and methods for treating conditions related to adrenocortical activity and/or excessive steroid production
#1404Methods of mitigating the negative effects of endurance exercise
#1405CELL TRANSPLANTATION DEVICE
#1406Methods of conditioning patients for T cell therapy
#1407High affinity T cell receptors and uses thereof
#1408Antisense oligomers for treatment of autosomal dominant mental retardation-5 and Dravet Syndrome
#1409COMBINATION OF A CARDIAC STEROID AND AN AKT INHIBITOR FOR THE TREATMENT OF CARDIOVASCULAR DISEASES AND DISORDERS
#1410Therapeutic method and therapeutic agent for atopic dermatitis in animals
#1411Combination therapy effective against microorganisms, including drug resistant microorganisms
#1412Purine compounds possessing anticancer activity
#1413Layered sustained-release microbeads and methods of making the same
#1414BTK Inhibitors to Treat Solid Tumors Through Modulation of the Tumor Microenvironment
#1415TREATMENT OF CANCER WITH DNAPK INHIBITORS
#1416COMBINATION OF LAQUINIMOD AND PRIDOPIDINE FOR TREATING NEURODEGENERATIVE DISORDERS, IN PARTICULAR HUNTINGTON'S DISEASE
#1417NOVEL PIPERIDINE COMPOUND OR SALT THEREOF
#1418Compositions and methods for selectively depleting senescent cells
#1419Therapeutic methods and combinations
#1420Sphingosine pathway modulating compounds for the treatment of cancers
#1421Rufinamide for use in the treatment of myotonia
#1422Pharmaceutical combinations for treating cancer
#1423METHODS OF TREATING CANCER BY ADMINISTERING A MEK INHIBITOR IN COMBINATION WITH A PROTEASOME INHIBITOR
#1424DBH inhibitors for treating memory loss
#1425COMBINATION THERAPY FOR TREATMENT OF MELANOMA
#1426Blended cannabis compounds and methods of making the same
#1427DOSAGE FORMS AND THERAPEUTIC USES OF L-4-CHLOROKYNURENINE
#1428METHODS AND COMPOSITIONS FOR TREATING PERIPHERAL NEUROPATHY
#1429PPAR-alpha agonist treatment of neuropsychiatric disorders
#1430Sphingosine pathway modulating compounds for the treatment of cancers
#1431Methods for treating cancer
#1432Deacetylnemorone abietane diterpenoids for use in cancer treatment
#1433Nucleic acid nanocapsules for drug delivery and targeted gene knockdown
#1434Choroidal neovascularization suppressor or drusen formation suppressor, and method for assessing or screening for same
#1435METHOD FOR DETECTING INFECTIOUS PARVOVIRUS IN PHARMACEUTICAL PREPARATIONS
#1436Method for reducing or inactivating viral and microbial content in the processes for the manufacture of pancreatin
#1437PD-1 SIGNAL INHIBITOR COMBINATION THERAPY
#1438Pan-ELR+ CXC chemokine antibodies
#1439VARIANT ANTIBODIES FOR SITE-SPECIFIC CONJUGATION
#1440Crystalline forms of a Bruton's tyrosine kinase inhibitor
#1441Crystalline forms of a Bruton's tyrosine kinase inhibitor
#14421H-pyrrolo [2,3-b] pyridine derivatives and their use as kinase inhibitors
#1443VITAMIN D RECEPTOR-COREGULATOR INHIBITORS
#1444Bioorthogonal compositions
#1445Biomaterials for delivery of blood extracts and methods of using same
#1446Method of reducing reactogenicity induced by administration of vaccine or immunogenic composition
#1447ENHANCED THERAPEUTIC USAGE OF A PURINE NUCLEOSIDE PHOSPHORYLASE OR NUCLEOSIDE HYDROLASE PRODRUG
#1448High concentration alpha-glucosidase compositions for the treatment of pompe disease
#1449Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl) amino) caprylic acid
#1450METHODS AND COMPOSITIONS FOR REGULATING SRCA2A EXPRESSION LEVELS IN MYOCARDIAL INFARCTION
#1451Use of thiosulfate to potentiate the anti-pathogenic effect of lactobacilli
#1452PRODUCT AND METHOD FOR TREATMENT OF BIOFILM, INCLUDING CONTROL OF SUBSTRATE COLONIZATION AND TREATMENT OF INFECTION
#1453Pharmaceutical compositions and their use for treatment of cancer and autoimmune diseases
#1454System and method for diagnosis and treatment
#1455Pharmaceutical compositions containing testosterone and an aromatase inhibitor
#1456MAO inhibitors and their conjugates as therapeutics for the treatment of brain cancer
#14577-benzyl-4-(methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-A]pyrido[3,4-E]pyrimidin-5 (1H)-one, salts thereof and methods of using the same in combination therapy
#1458Methods and compositions for inhibition of polymerase
#1459METHOD AND THERAPEUTIC/COSMETIC TOPICAL COMPOSITIONS FOR THE TREATMENT OF ROSACEA AND SKIN ERYTHEMA USING A1-ADRENOCEPTOR AGONISTS
#1460Pharmaceutical compositions comprising clofazimine analog compound B746 or clofazimine analog compound B826
#1461Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects
#1462VAP-1 INHIBITORS FOR TREATING PAIN
#1463METHODS FOR THE TREATMENT OF DISEASES AMELIORATED BY PDE4 INHIBITION USING DOSAGE TITRATION OF APREMILAST
#1464Tesofensine and beta blocker combination formulations
#1465Treatment of tinnitus through modulation of chloride co-transporter NKCC1 in the auditory system
#1466Method of Treatment of Alopecia with Monoterpenoids
#1467FATTY ACID MONOGLYCERIDE COMPOSITIONS
#1468X-RAY CONTRAST MEDIA COMPOSITIONS AND METHODS OF USING THE SAME TO TREAT, REDUCE OR DELAY THE ONSET OF MIGRAINE
#1469Methods and compositions for treatment of demyelinating diseases
#1470Therapy for kinase-dependent malignancies
#1471Curcumin-based compositions and methods of use thereof
#1472Low-temperature inhalation administration of cannabinoid entities
#1473Enzyme delivery systems and methods of preparation and use
#1474Systems and methods for monitoring of fractional gluconeogenesis and targeting of fractional gluconeogenesis via nutritional support
#1475Methods and Apparatus for Creating Particle Derivatives of HDL with Reduced Lipid Content
#1476Cyclic dinucleotides for cytokine induction
#1477Benzylideneguanidine derivatives and therapeutic use for the treatment of protein misfolding diseases
#14783-DIMENSIONAL CARDIAC FIBROBLAST DERIVED EXTRACELLULAR MATRIX
#1479Methods for reducing cardiotoxicity from chemotherapy by administering humanin analog compositions
#1480Method of identifying a biologically-active composition from a biofilm
#1481Cell preparations for extemporaneous use, useful for healing and rejuvenation in vivo
#1482Methods of treatment with natural killer cells matched for killer immunoglobulin receptor type
#1483Combination Therapeutic Agent For The Treatment Of Macular Degeneration
#1484CONJOINT THERAPIES WITH INHIBITORS OF GLUCOSE PRODUCTION
#1485Treatment of Biliary Duct Cancer
#1486Reducing memory loss in mammals suffering from Alzheimer's disease
#1487Nicotinamide riboside and pterostilbene compositions and methods for treatment of skin disorders
#1488PHARMACEUTICAL COMBINATIONS COMPRISING A PI3K INHIBITOR FOR THE TREATMENT OF CANCER
#1489TREATMENT METHOD BY COMBINED USE OF MDM2 INHIBITOR AND BTK INHIBITOR
#1490Combination therapy for treatment of restenosis
#1491Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes
#1492Use of amisulpride as an anti-emetic
#1493Use of composition of multivitamin in preparing drug for stimulating gastrointestinal system motility
#1494PHARMACEUTICAL COMBINATION COMPRISING METFORMIN AND DIHYDROQUERCETIN AND ITS USE FOR THE TREATMENT OF CANCER
#1495BROMFENAC BIOAVAILABILITY
#1496METHODS AND COMPOSITIONS FOR TREATING DEMYELINATING DISEASES USING SOBETIROME OR A SOBETIROME PRODRUG AND A PPAR ACTIVATOR
#1497Drug combination with antitumor effects
#1498Methods of treatment of cancer by continuous infusion of coenzyme Q10
#1499MICRORNA-198 AS A TUMOR SUPPRESSOR IN OVARIAN CANCER
#1500Alkylated cyclodextrin compositions and processes for preparing and using the same